Humanized antibodies that recognize beta amyloid peptide

Details for Australian Patent Application No. 2004245989 (hide)

International Classifications

Event Publications

5 January 2006 PCT application entered the National Phase

PCT publication WO2004/108895 Priority application(s): WO2004/108895

20 December 2007 Assignment before Grant

Neuralab Limited; Wyeth The application has been assigned to Wyeth; Elan Pharma International Limited

8 April 2010 Alteration of Name

The name of the applicant has been altered to Elan Pharma International Limited; Wyeth LLC

16 June 2011 Application Accepted

Published as AU-B-2004245989

1 September 2011 Assignment before Grant

Wyeth LLC; Elan Pharma International Limited The application has been assigned to Wyeth LLC; Janssen Alzheimer Immunotherapy 2005

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.